NCT06537505

A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors

An Exploratory Clinical Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Advanced Second-line and Above Solid Tumors

• Status: Not Yet Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Beidahuang Industry Group General Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This is a multi-center, phase Il trial to evaluate the efficacy and safety of microwave ablation combined with immunotherapy ± anti-angiogenic drugs in the treatment of advanced second-line and above solid tumors.

Detailed description

This study plans to recruit 60 patients witha dvanced second-line and above solid tumors observe and evaluate the effectiveness and safety of microwave ablation combined with immunotherapy ± anti-angiogenic drugs.

Conditions

• Solid Tumor

Interventions

Type	Name	Description
DRUG	Adebrelimab	Q3W,IV
DRUG	Apatinib	QoD
PROCEDURE	microwave ablation	microwave ablation

Timeline

• Start date: 2024-08-05
• Primary completion: 2027-04-01
• Completion: 2027-08-31
• First posted: 2024-08-05
• Last updated: 2024-08-05